Partnership will focus on the development of new therapeutics for Autosomal Dominant Polycystic Kidney Disease Glasgow Scotland and Sheffield UK 12th December 2016 Mironid Ltd a leader in cell signallingdirected drug development and the University of She...
Mironid is a Scotland-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of autosomal dominant polycystic kidney disease.